EPO Protein, Human Growth Factor Family reducing over (under) treatment and

reducing over (under) treatment and associated side effects

CD319) induces proliferation and autocrine cytokine expression on human B lymphocytes

a sialic acid binding receptor expressed by resident and inflammatory macrophage populations

and gastric cancers

EPO Protein, Human Growth Factor Family reducing over (under) treatment andProduct Specification Species Human Synonyms Erythropoietin, EPO; Erythropoietin, Epoetin, EPO Accession P01588 Amino Acid Sequence Ala28 Arg193 Expression System CHO Molecular Weight 28 40 kDa(Reducing) Purity 95%, by SDS PAGE under reducing conditions Endotoxin <0. 1EU g Conjugation Unconjugated Tag No Tag Physical Appearance Lyophilized Powder Storage Buffer PBS, pH7. 4 Reconstitution Reconstitute at less than 1 mg mL according to the size in